Pharmafile Logo

gut microbiome

- PMLiVE

UKHSA publishes five-year strategy to detect risk-posing pathogens in UK

The strategy will help to improve the UK's response to infectious disease threats

- PMLiVE

Study finds vaccination against COVID-19 reduces long COVID symptoms

The results could help inform public health strategies and vaccination campaigns

- PMLiVE

World Health Organization adds second malaria vaccine to prequalification list

The addition is expected to result in sufficient malaria vaccine supply for children

- PMLiVE

UK-India research project trialling easy-to-use UTI test to support fight against AMR

AMR has been declared by WHO as one of the top ten threats to global public health

- PMLiVE

New report reveals antibiotic underdosing could be leading cause of AMR in UK

AMR has been declared by WHO as one of the top ten threats to global public health

Can Cinderella save us?

Study finds AI detects AMR faster than gold-standard testing

The method detected AMR with at least 80% accuracy on a per-cell basis, within 30 minutes

Can Cinderella save us?

World AMR Awareness Week to focus on urgent actions needed to prevent AMR

AMR has been designated by WHO as one of the top ten threats to global public health

- PMLiVE

National surveillance data reveals increase in antibiotic resistant infections in England

The number of deaths due to severe antibiotic resistant infections also increased in 2022

- PMLiVE

UK antibiotic subscription model found by OHE as key to supporting investment

The OHE report offers valuable insights into investor views of the subscription model

- PMLiVE

University of Oxford launches new trial to enhance flu and COVID-19 vaccines

Results from the study are expected to help increase the protection of future vaccines

- PMLiVE

WHO releases 13 interventions to help address antimicrobial resistance

The organisation has declared AMR as one of the top ten threats to global public health

- PMLiVE

WHO recommends second malaria vaccine for children

The addition of R21/Matrix-M to the organisation’s list is expected to result in sufficient malaria vaccine supply

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links